Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

Epigenetics is involved ... gene expression. The most common HDAC inhibitors include phenylbutyric acid, SAHA, depsipeptide, and valproic acid (Egger et al., 2004). Caution in using epigenetic ...

Dravet syndrome and other developmental epileptic encephalopathies are rare but devastating conditions that cause a host of ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, ...

Announcing a new article publication for BIO Integration journal. Neurologic disorders currently affect approximately 100 million people worldwide.

Elixirgen Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of rare diseases and aging-associated diseases using its ZSCAN4 technology and mRNA platform ...

INTELLIGENCE. BREAKING NEWS AT NOON. THE SOUTH CAROLINA LAW ENFORCEMENT DIVISION IS INVESTIGATING A SHOOTING INVOLVING LAW ENFORCEMENT. THE INCIDENT HAPPENED EARLIER THIS MORNING ALONG HIGHWAY 183 ...

Spark Therapeutics is on the cusp of gaining the first ever approval for a gene therapy from the FDA, a groundbreaking treatment which restores vision to children and adults with a rare inherited ...

Languages: English. A survey has found that over 80 percent of military families think the U.S. will be involved in a "major conflict" soon. Blue Star Families, an organization dedicated to ...